TSRL, Inc. is a privately-owned preclinical accelerator based in Ann Arbor, Michigan with a mission to advance promising compounds for treating severe and multi-drug resistant infections.
Therapeutic Systems Research Laboratories (TSRL), Inc. is a privately owned preclinical accelerator based in Ann Arbor, Michigan. Our 7,200 sq. ft. facility has 5,000 sq. ft. of wet lab space, and includes: analytical chemistry, formulation, cell culture, and in vivo testing. We employ nine full-time employees and generate revenue from royalties and grants.
We build on our success co-developing technologies through academic partnerships by providing infrastructure, expertise, and an avenue to non-dilutive funding. In an effort to advance our lead candidates into clinical development, we have developed an asset-centric portfolio built on promising lead-stage anti-infective compounds.
DNA Antivirals (.pdf)
Bridging the Gap
Questions? Contact Us ›